A total of 16,912 Jan Aushadhi Kendras (JAKs) have been opened till June, under the Pradhan Mantri Bhartiya Janaushadhi ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

Uttar Pradesh has moved far ahead in terms of establishing government's low cost, quality generic medicines retail stores Jan Aushadhi Kendras (JAKs) in the State, with more than 20 per cent of the ...

The Government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to make quality generic medicines available ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...

Various schemes being implemented by the Centre to realise the vision of Aatmanirbhar Bharat in the pharmaceutical sector ...

Jagadeesan Joins Team India, Takes Part In Training Session Ahead Of Crucial 5th Test At The Oval; Video Vasai-Virar Illegal ...

Cipla , India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs.

Stockholm, Sweden - July 24, 2025 - Biosergen AB ("Biosergen" or the "Company"), a clinical-stage biotechnology company developing therapies for life-threatening fungal infections, today announces the ...

Number of schemes are being implemented to realise the vision of Atmanirbhar Bharat in the pharmaceutical sector and to ...

The company raised its full-year 2025 guidance for revenue, net income, and earnings per share. These 10 stocks could mint the next wave of millionaires › Medpace (NASDAQ:MEDP), a clinical contract ...

Indian pharma companies are expected to report largely steady performance in Q1FY26. While revenue growth is anticipated—driven particularly by a robust domestic market—margins are likely to face ...